AI in Healthcare: Market Growth to Accelerate Rapidly Over Next Decade
The Global Artificial Intelligence (AI) in Healthcare Market is on a remarkable trajectory, poised to expand from a valuation of US$ 9.01 billion in 2022 to an astounding US$ 187.76 billion by the end of 2031, advancing at a compound annual growth rate (CAGR) of 40.1% from 2023 to 2031. This unprecedented growth is driven by the increasing adoption of AI technologies in various healthcare applications, from patient care and management to streamlining administrative processes.
Transformative Potential of AI in Healthcare
AI technologies are revolutionizing healthcare delivery, offering significant benefits such as improved patient outcomes, enhanced diagnostic accuracy, and streamlined administrative operations. AI applications in healthcare include machine learning (ML) algorithms, computer vision, natural language processing, robotics, and deep learning, which collectively contribute to better preventative care, accurate diagnosis, and effective treatment plans.
AI and automation solutions are not only lowering healthcare costs but also reforming critical administrative functions like patient registration, data entry, and claims processing. These advancements enable healthcare providers to meet clinical needs more efficiently and safely, thereby driving global demand for AI healthcare solutions.
Surge in Investments and Government Initiatives
The AI in healthcare sector is witnessing a surge in investments from governments, healthcare organizations, and private investors. Recognizing the transformative potential of AI, these stakeholders are increasingly funding research and development to improve patient care and operational efficiency.
For instance, in March 2023, the UK government invested US$ 17 million in AI research for cancer diagnostics, rare disease identification, and improving the speed and accuracy of diagnoses. Similarly, the National Institutes of Health (NIH) in the U.S. allocated US$ 130 million over four years to accelerate AI integration in healthcare.
Government initiatives are creating a supportive environment for AI adoption in healthcare. These initiatives include funding for AI research, regulatory support, and partnerships with healthcare organizations. For example, the U.S. General Services Administration (GSA) launched the Applied AI Healthcare Challenge to encourage innovative AI solutions in medical care.
Download Sample PDF from Here- https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85584&utm_source=Openpr&utm_medium=Amit
Regional Market Dynamics
North America dominated the AI in healthcare market in 2022 and is expected to maintain its leading position throughout the forecast period. The region's growth is driven by high demand for operational efficiency in healthcare organizations and robust government support for AI initiatives.
Meanwhile, the Asia Pacific region is projected to experience substantial growth due to increased investments in healthcare infrastructure and the presence of numerous AI companies collaborating with healthcare providers to develop innovative AI applications.
Key Market Players and Developments
Prominent companies in the AI in healthcare market include IBM Corporation, NVIDIA Corporation, Microsoft Corporation, Intel Corporation, GE HealthCare, Siemens Healthineers AG, Medtronic Plc, Koninklijke Philips N.V., Google LLC, CloudMinds Technology Inc., General Vision Inc., and BenevolentAI.
Recent strategic developments in the market include Terumo Corporation's partnership with Siemens Healthcare GmbH in January 2023 to enhance AI technology penetration in India. In February 2022, Nuance Communications, Inc. collaborated with NVIDIA to bring AI-powered diagnostic tools to radiologists, aiming to improve patient care quality while reducing costs.
Market Segmentation
The AI in healthcare market is segmented by component, application, end-user, and region. Key components include software/platforms and services, while applications range from robot-assisted surgery to medical imaging and diagnostics. End-users encompass hospitals, healthcare providers, pharmaceutical, and biotechnology companies.
Regions covered in the analysis include North America, Europe, Asia Pacific, Middle East & Africa, and South America, with detailed insights into key countries within these regions.
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]